Navigation Links
Cepheid Reports 2013 First Quarter Results
Date:4/18/2013

/p>

$
313$
(5,526)Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:Depreciation and amortization of property and equipment

3,7682,475Amortization of intangible assets 

1,5601,441Unrealized exchange differences

444-Stock-based compensation related to employees and consulting services rendered

6,2775,498Changes in operating assets and liabilities:Accounts receivable 

(1,047)1,943Inventory 

(7,814)(5,457)Prepaid expenses and other current assets 

(3,528)(3,538)Other non-current assets

168(768)Accounts payable and other current liabilities 

8,342(1,600)Accrued compensation 

(614)(3,071)Deferred revenue 

2,608251Net cash provided by (used in) operating activities 

10,477(8,352)Cash flows from investing activities:Capital expenditures 

(8,929)(4,587)Payments for technology licenses 

(1,000)-Cost of acquisitions, net

-(16,992)Net cash used in investing activities 

(9,929)(21,579)Cash flows from financing activities:Net proceeds from the issuance of common shares and exercise of stock options

6,14519,409Principal payment of notes payable

(41)-Net cash provided by financing activities 

6,10419,409Effect of exchange rate change on cash

(443)(495)Net increase (decrease) in cash and cash equivalents 

6,209(11,017)Cash and cash equivalents at beginning of period 

95,779115,008Cash and cash equivalents at end of period

$
,988$
3,991CEPHEIDRECONCILIATION OF GAAP TO NON-GAAP MEASURES (UNAUDITED)(in thousands, except per share data)Three Months Ended
March 31,20132012Cost of sales$
42,892$
35,608  Stock compensation expense(542)(635)  Amortization of purchased intangible assets(854)(333)Non-GAAP measure of cost of sales$
41,
'/>"/>

SOURCE Cepheid
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
2. Cepheid Announces Board of Directors Changes
3. Cepheid Reports 2012 Second Quarter Results
4. Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
5. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
6. Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year
7. Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria
8. Cepheid to Webcast Upcoming Financial Presentations
9. Cepheid Reports Fourth Quarter and Full Year 2011 Results
10. Cepheid Welcomes Senior Vice President of Human Resources
11. Global Nano-Materials Market 2002-2016: Nano-Materials Industry, Production Volumes, Revenues and End User Market Demand - MarketResearchReports.Biz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015  Pfenex Inc. (NYSE MKT: ... of biosimilar therapeutics, today announced that it will be ... Marquis on March 2 nd at 3pm PST. Patrick ... a panel discussing the current state of the biosimilar ... . For more information on CALBIO ...
(Date:2/26/2015)... NEW YORK , Feb. 26, 2015 ... commenced Factual Stock Report coverage on MabVax Therapeutics ... Inc. (MBVX) is a clinical stage biotechnology company focused ... address unmet medical needs in the treatment of cancer. ... products based on the protective immune responses generated by ...
(Date:2/26/2015)...   Regulus Therapeutics Inc . (NASDAQ: ... development of innovative medicines targeting microRNAs, today announced that ... Executive Officer of Regulus, will present a company overview ... Healthcare Conference on Wednesday, March 4, 2015 at 9:20 ... Boston Marriott Copley Place.  The presentation ...
(Date:2/26/2015)... , Feb. 26, 2015  NuGene International, Inc. ... products for skin and hair rejuvenation, has announced ... agency of record for investor relations and strategic ... our distribution, sales and diversification strategies – and ... and prospective shareholders," stated Ali Kharazmi CEO of ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 2NuGene International, Inc. Selects Capital Market Relations for Strategic Investor Relations 3
... (OTC Bulletin Board: WGBS), a leading developer of ... research systems,today announced that Kumar Kastury, Ph.D., vice ... on its SmartChip(TM),Real-Time PCR System at the Cambridge ... will be held June 8-11, 2008, at,the Fairmont ...
... OncoGenex Technologies Inc. will,present at the Needham & ... June 11 at 3 p.m. ET at the ... Officer, Scott Cormack, will,provide a corporate overview at ... recent data presentations from the American Society of,Clinical ...
... Powerful New Tool for Early Identification of High Risk ... Intervention Can Help Prevent Disease Progression, ... announced,today at the 68th Scientific Sessions of the American ... its novel PreDx(TM) Diabetes,Risk Test, a first-of-its-kind predictive tool ...
Cached Biology Technology:WaferGen to Present at the Ninth Annual Beyond Genome Conference 2OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 2OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 3Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 2Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 3Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 4
(Date:2/10/2015)... Inc. (NYSE: ALR), a global leader in rapid ... ended December 31, 2014. Namal Nawana, ... "We made substantial progress in the fourth quarter ... rapid diagnostics and delivering against our financial plans.  ... January enabled us to substantially reduce our debt, ...
(Date:2/5/2015)... N.C. , Feb. 5, 2015  Marken is ... logistics company and has launched a new marketing campaign ... Logistics Organization (CLO).  The new campaign focuses on ... patient, protocol and shipments. The first headline ... , aligns Marken,s priorities with its client,s priorities. Marken ...
(Date:2/5/2015)... , Jan. 27, 2015   Marvin ... globally deployed, innovative test solutions for military, ... delivery of its TS-323 GENASYS Test ... Company (LMSSC). GENASYS is a high-performance PXI-based ... mission-critical applications that require performance functional testing. ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... release is available in <A HREF=",http://chinese.eurekalert.org/zh/pub_releases/2010-06/sfeb-apr062110.php,">Chinese . ... progressive disease, marked by shortness of breath and ... Increased pressure in the pulmonary artery and its ... endothelial and smooth muscle cells leading to excessive ...
... 2010)The nations of East and Central Africa have ... of humankind,s closest relativesthe eastern chimpanzeefrom hunting, habitat ... announcement made today by the Wildlife Conservation Society ... Nature (IUCN). The ambitious plantitled "Eastern ...
... National Oceanography Centre and the University of Glasgow show ... dynamics of plankton patches in the upper ocean. ... numbers in the sunlit upper ocean. Through the process ... starting with just water and carbon dioxide, which is ...
Cached Biology News:A possible role for Smurf1 in pulmonary arterial hypertension 2African nations commit to saving chimps 2African nations commit to saving chimps 3Ocean stirring and plankton patchiness 2
Request Info...
Recombinant Rhesus Macaque IFN-alpha...
9 D10...
... 500 g protein ... mouse whole cell lysate; Abelson transformed ... provided as Western blotting positive control, ... freezing and thawing should be minimized, ...
Biology Products: